β amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: Usage of a novel blood brain barrier endothelial cell model system

References

• Selkoe D J. Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 1996; 27: 18295–18292
   Google Scholar
• Selkoe D J. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Ann Rev Cell Biol 1994; 10: 373–403
   PubMedGoogle Scholar
• Yankner B A, Mesulam M M. β-Amyloid and the pathogenesis of Alzheimer's Disease. New England J Med 1991; 325: 1849–1857
   PubMed Web of Science ®Google Scholar
• Haas C, De Strooper B. The presenilins in Alzheimer's disease-proteolysis holds the key. Science 1999; 285: 916–191
   Google Scholar
• Wolfe M S, De Los Angeles J, Miller D D, Xia W, Selkoe D J. Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease. Biochem. 1999; 38: 11223–11230
   PubMed Web of Science ®Google Scholar
• Wilson C A, Doms R W, Lee V M. Intracellular APP processing and A beta production in Alzheimer's disease. J Neuropathol Exp Neurol 1999; 58: 787–794
   PubMed Web of Science ®Google Scholar
• Price D, Sisodia S, Gandy S. Amyloid β amyloidosis in Alzheimer's disease. Curr Opinion Neurol 1995; 8: 268–274
   PubMed Web of Science ®Google Scholar
• Hartmann T, Bieger S C, Bruhl B, Tienari P J, Ida N, Allsop D, Roberts G W, Masters C L, Dotti C G, Unsicker K, Beyreuther K. Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides. Nature Med 1997; 3: 1016–1020
   PubMed Web of Science ®Google Scholar
• Sisodia S. β-Amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad. Sci U.S.A. 1994; 89: 6075–6079
   Web of Science ®Google Scholar
• Hardy J, Israel A. In search of the y-secretase. Nature 1999; 398: 466–467
   PubMed Web of Science ®Google Scholar
• Citron M, Teplow D, Selkoe D J. Generation of amyloid β protein from its precursor is sequence specific. Neuron 1995; 14: 661–670
   PubMed Web of Science ®Google Scholar
• Vassar R, Bennett B D, Babu-Khan S, Kahn S, Mendiaz E A, Denis P, Teplow D B, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile S, Jarosinski M A, Biere A L, Curran E, Burgess T, Louis J-C, Collins F, Treanor J, Rogers G, Citron M. β-secretase cleavage of the Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999; 286: 735–741
   PubMed Web of Science ®Google Scholar
• Papastoitsis G, Siman R, Scott R, Abraham C R. Identification of a metalloprotease from Alzheimer's disease brain able to degrade the β-amyloid precursor protein and generate amyloidogenic fragments. Biochem 1994; 33: 192–199
   PubMed Web of Science ®Google Scholar
• Conn K J, Pietropaolo M, Ju S T, Abraham C R. Monoclonal antibodies against the human metalloprotease EC 3.4.24.15 label neurofibrillary tangles in Alzheimer's disease brain. J Neurochem 1996; 66: 2011–2018
   PubMed Web of Science ®Google Scholar
• Abraham C R, Driscoll J, Potter H, Van Nostrand W E, Tempst P. A calcium-activated protease from Alzheimer's disease brain cleaves at the N-terminus of the amyloid β-protein. Biochem Biophys Res Commun 1991; 174: 790–796
   PubMed Web of Science ®Google Scholar
• Rubin L L, Hall D E, Porter S, Barbu K, Cannon C, Horner H C, Janatpour M, Liaw C W, Manning K, Morales J, Tanner L I, Tomaselli K J, Bard F. A cell culture model of the blood brain barrier. J Cell Biol 1991; 115: 1725–1735
   PubMed Web of Science ®Google Scholar
• Van Nostrand W, Davis-Salinas J, Saporito-Irwin S. Amyloid β-protein induces the cerebrovascular cellular pathology of Alzheimer's disease and related disorders. Ann N Y Acad. Sci, USA 1996; 777: 297–302
   PubMed Web of Science ®Google Scholar
• Van Nostrand W, Rozemuller A, Chung R, Cotraan C, Saporito-Irwin S. Amyloid β-protein precursor in cultured leptomeningeal smooth muscle cells. Amyloid: Int. Jour Exp Clin Invest 1994; 1: 1–7
   Web of Science ®Google Scholar
• Wells J M, Amaratunga A, McKenna D C, Abraham C R, Fine R E. Amyloid β-protein precursor and apolipoprotein E production in cultured cerebral endothelial cells. Amyloid: Int J Clin Invest 1995; 2: 229–233
   Web of Science ®Google Scholar
• Wisniewski H, Frackowiak J, Zoltowska A, Kim K. Vascular β-amyloid in Alzheimer's disease angiopathy is produced by proliferating and degenerating smooth muscle cells. Amyloid: Int J Exp Clin Invest 1994; 1: 8–16
   Web of Science ®Google Scholar
• Wisniewski H, Wegiel J, Wang K, Lach B. Ultra-structural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol 1992; 84: 117–127
   PubMed Web of Science ®Google Scholar
• Davies T, Long H, McMenamin M, Rathbun W, Seetoo K, Tibbies H, Billingslea A, Sgro K, Fishman J, Levesque C, Smith S, Wells J, Simons E. Activated Alzheimer disease platelets retain more beta-amyloid precursor protein. Neurobiol Aging 1997; 18: 147–153
   PubMed Web of Science ®Google Scholar
• Li Q, Evin G, Small D, Multhaup G, Beyreuther K, Masters C. Proteolytic processing of Alzheimer's disease PA4 amyloid precursor protein in human platelets. J Biol Chem 1995; 270: 14140–14147
   PubMed Web of Science ®Google Scholar
• Li Q X, Whyte S, Tanner J E, Evin G, Beyreuther K, Masters C L. The amyloidogenic Aβ fragment of Alzheimer's disease is released from human platelets. Laboratory Invest. 1997; 784: 461–469
   Google Scholar
• Chen M, Inestrosa N, Ross G, Fernandez H. Platelets are the primary source of amyloid β-peptide in human blood. Biochem Biophys Res Commun 1995; 213: 96–103
   PubMed Web of Science ®Google Scholar
• Abraham C R, Selkoe D J, Potter H. Immunochemical identification of the serine protease inhibitor a1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 1988; 52: 487–501
   PubMed Web of Science ®Google Scholar
• Wisniewski T, Frangione B. Apolipoprotein E: a pathologic chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992; 135: 235–238
   PubMed Web of Science ®Google Scholar
• Davies T, Long H, Tibbies H, Wells J, Rathbun W, Seetoo K, McMenamin M, Smith S, Feldman R G, Levesque C, Fine R E, Simons E R. Moderate and advanced Alzheimer's patients exhibit platelet activation differences. Neurobiol Aging 1997; 18: 155–162
   PubMed Web of Science ®Google Scholar
• Abraham C R, Razzaboni B L, Papastoitsis G, Picard E, Kanemaru K, Meckelein B, Mucke L. Purification and cloning of brain proteases capable of degrading the β-amyloid precursor protein. Ann NY Acad Sci 1992; 674: 174–179
   PubMed Web of Science ®Google Scholar
• Abraham C R, Marshall D, Tibbies H E, Sgro K, Otto K, Long H J, Billingslea A M, Fine R E, Levesque C A, Smith S J, Simons E R, Davies T A. Platelets and DAMI megakaryocytes possess β-secretase-like activity. J Lab Clin Med 1999; 130: 21–32
   Google Scholar
• Simons E R, Marshall D, Long H J, Otto K, Billingslea A, Tibbies H, Wells J, Eisenhauer P, Fine R E, Cribbs D H, Davies T A, Abraham C R. Blood brain barrier endothelial cells express candidate amyloid precursor protein-cleaving secretases. Amyloid: Int. J Exp Clin. Invest. 1998; 5: 153–162
   PubMed Web of Science ®Google Scholar
• Davies T A, Fine R E, Johnson R J, Levesque C A, Rathbun W H, Seetoo K F, Smith S J, Strohmeier G, Volicer L, Delva L, Simons E R. Non-age related differences in thrombin responses by platelets from male patients with advanced Alzheimer's disease. Biochem Biophys Res Commun. 1993; 194: 537–543
   PubMed Web of Science ®Google Scholar
• Davies T A, Billingslea A M, Long H J, Tibbies H, Wells J M, Eisenhauer P B, Smith S J, Cribbs D J, Fine R E, Simons E R. Brain endothelial cell enzymes cleave platelet-retained amyloid precursor protein. J Lab Clin Med 1998; 132: 341–350
   PubMed Web of Science ®Google Scholar
• Davies T, Long H, Rathbun W, Sgro K, Tibbies H, Smith S, Seetoo K, McMenamin M, Johnson R, Wells J, Levesque C, Fine R, Simons E. Platelets from patients with Alzheimer's disease or other dementias exhibit disease-specific and apolipoprotein E- correlatable defects. Amyloid: Int J Exp Clin Invest 1996; 3: 13–19
   Web of Science ®Google Scholar
• Eisenhauer P, Wells J, McKenna D C, Shanmugaratnam J, Fine R E, Billingslea A M, Long H J, Simons E R, Davies T A. Beta-APP processing/regulation by interleukin 1 in brain endothelial cells. Alzheimer's Report 1998; 1: 241–249
   Google Scholar
• Tamaoka A, Kalaria R N, Lieberburg I, Selkoe D J. Identification of a stable fragment of the Alzheimer amyloid precursor containing the P-protein in brain microvessels. Proc Natl Acad Sci U.S.A. 1992; 89: 1345–1349
   PubMed Web of Science ®Google Scholar
• Tagliavini F, Ghiso J, Timmers W F, Giaccone G, Bugiani O, Frangione B. Coexistence of Alzheimer's amyloid precursor protein and amyloid in cerebral vessel walls. Lab Invest. 1990; 62: 761–767
   PubMed Web of Science ®Google Scholar
• Buee L, Hof P, Bouras C, Delacourte A, Perl D, Morrison J, Fillit H. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol 1994; 87: 469–480
   PubMed Web of Science ®Google Scholar
• Stewart P, Hayakawa K, Akers M, Vinters H. A morphometric study of the blood-brain barrier in Alzheimer's disease. Laboratory Invest. 1992; 67: 734–742
   PubMed Web of Science ®Google Scholar
• Behl C, Davis J, Lesly R, Schubert D. Hydrogen peroxide mediates amyloid beta toxicity. Cell 1994; 77: 817–827
   PubMed Web of Science ®Google Scholar
• Mattson M, Furukawa K, Bruce A, Mark R, Blanc E. Calcium homeostasis and free radical metabolism as convergence points in the pathophysiology of dementia. Molecular Mechanisms of Dementia, W. Wasco, R. Tanzi, 1996; 103–143
   Google Scholar
• Frackowiak J, Zoltowska A, Wisniewski H. Non-fibrillar beta-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer's disease. J Neuropath Exp Neurol 1994; 53: 637–645
   PubMed Web of Science ®Google Scholar
• Wisnewski H, Frackowiak J, Zoltowska A, Kim K. Vascular P-amyloid in Alzheimer's disease angiopathy is produced by proliferating and degenerating smooth muscle cells. Amyloid: Int Jour Exp Clin Invest 1994; 1: 8–16
   Web of Science ®Google Scholar
• Chen M, Inestrosa N, Ross G, Fernandez H. Platelets are the primary source of amyloid β-peptide in human blood. Biochem Biophys Res Commun 1995; 213: 96–103
   PubMed Web of Science ®Google Scholar
• Joachim C, Morris J, Selkoe D. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases. Ann Neurol 1987; 25: 50–56
   Google Scholar
• Schlossmacher M G, Ostaszewski B L, Hecker L I, Celi A, Haass C, Chin D, Lieberburg I, Furie B C, Furie B, Selkoe D J. Detection of distinct isoform patterns of the β-amyloid precursor protein in human platelets and lymphocytes. Neurobiol Aging 1992; 13: 421–434
   PubMed Web of Science ®Google Scholar
• Li Q X, Berndt M C, Bush A I, Rumble B, Mackenzie I, Friedhuber A, Beyreuther K, Masters C L. Membrane-Associated forms of the pA4 amyloid protein precursor of Alzheimer's disease in human platelet and brain: surface expression on the activated human platelet. Blood 1994; 8: 133–142
   Google Scholar
• Snowdon D A, Greiner L H, Mortimer J A, Riley K P, Greiner P A, Markersbery W R. Brain infarction and the clinical expression of Alzheimer's disease: The Nun's Study. JAMA 1997; 277: 813–817
   PubMed Web of Science ®Google Scholar
• Evin G, Beyreuther K, Master C. Alzheimer's Disease Alzheimer Precursor Protein (AβPP): Proteolytic processing, secretase and PA4 amyloid production. Amyloid: Int J Clin Invest 1994; 1: 263–280
   Web of Science ®Google Scholar
• Zhong Z, Higaki J, Murakami K, Wang Y, Catalano R, Quon D, Cordell B. Secretion of P-amyloid precursor protein involves multiple cleavage sites. J Biol Chem 1994; 269: 627–632
   PubMed Web of Science ®Google Scholar
• Sisodia S. P-Amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci USA 1992; 89: 6075–6079
   PubMed Web of Science ®Google Scholar